Trust Company of Vermont’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-106
| Closed | -$10K | – | 845 |
|
|
2023
Q2 | $10K | Hold |
106
| – | – | ﹤0.01% | 672 |
|
|
2023
Q1 | $10.7K | Hold |
106
| – | – | ﹤0.01% | 700 |
|
|
2022
Q4 | $12.7K | Hold |
106
| – | – | ﹤0.01% | 654 |
|
|
2022
Q3 | $11K | Hold |
106
| – | – | ﹤0.01% | 706 |
|
|
2022
Q2 | $10K | Buy |
+106
| New | +$10K | ﹤0.01% | 685 |
|